Document Details

Filing Date
Aug 10, 2020
Document Date
Aug 10, 2020
Form Description
Post-effective amendment to an S-Type filing
Filing Group
Registration Statements
Company
BioLineRx
Issuer
BioLineRx Ltd.
Shape
Potential life-changing treatments are on the way

Each molecule in our development pipeline is carefully selected for its potential ability to improve upon the standard of care, delivering maximum value to patients